A Health Care ETF Full of Takeover Targets

When the topic of health care sector mergers and acquisitions is raised, close attention is often paid to the biotechnology sub-sector. Conventional wisdom dictates that cash-rich blue chip pharmaceuticals firms facing patent cliffs will use some of that cash to acquire biotech firms and the...